Passer au contenu principal
Centre intégré universitaire de santé
et de services sociaux de l'Est-de-l'Île-de-Montréal

Centre intégré universitaire de santé et de services sociaux de l'Est-de-l'Île-de-Montréal



The Nephrology Department at Hôpital Maisonneuve-Rosemont focuses on the study, diagnosis and care of kidney diseases. The department’s nephrology research concentrates on kidney failure as part of a scientific program that brings together the fundamental, translational and clinical continuum and addresses the following main themes :

Pharmacology and epidemiology

Research in pharmacology and epidemiology is mainly interested in the consequences of renal failure on the kinetics and dynamics of drugs.

Epidemiology and evaluative research

In nephrology, epidemiological and evaluative research is aimed at the population-based study of morbidity and mortality, as well as the associated risk factors, of patients with renal insufficiency, the deployment of advanced nursing practice roles, creation of the Glomerular Disease Registry - Quebec and transitions between the different renal replacement therapy modalities, including autonomous dialysis.

Immunotherapy and cell therapy

Research in immunotherapy and cell therapy aims to optimize the therapeutic potential of kidney transplantation.

To this end, fundamentalist and clinical researchers are very active and participate in more than thirty university studies or in connection with the pharmaceutical industry. Members of the University of Montreal's Nephrology Research Consortium, which brings together the largest hospital institutions in the Montreal agglomeration, they have also largely developed the scientific program of the Consortium whose mission is to promote cutting-edge research on kidney disease.

Head : Dr Jean-Philippe Lafrance, M., MSc
Assistant head :  Dr Vincent Pichette, MD, PhD